Evidence map›Paper›PMID 34262565›Full record

ArticleFrontiers in immunology2021

The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.

Yan Chen, Zepang Sun, Wanlan Chen, Changyan Liu, Ruoyang Chai, Jingjing Ding, Wen Liu, Xianzhen Feng, Jun Zhou, Xiaoyi Shen and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Advances in the molecular subtyping of gastric cancer.World journal of surgical oncology · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yan ChenDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Zepang SunDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wanlan ChenDepartment of Cardiology, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Changyan LiuDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Ruoyang ChaiDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Jingjing DingDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Wen LiuDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Xianzhen FengDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Jun ZhouDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Xiaoyi ShenDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Shan HuangDepartment of Endocrinology, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Zhongqing XuDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) is a highly heterogeneous tumor with different responses to immunotherapy. Identifying immune subtypes and landscape of GC could improve immunotherapeutic strategies. Methods: Based on the abundance of tumor-infiltrating immune cells in GC patients from The Cancer Genome Atlas, we used unsupervised consensus clustering algorithm to identify robust clusters of patients, and assessed their reproducibility in an independent cohort from Gene Expression Omnibus. We further confirmed the feasibility of our immune subtypes in five independent pan-cancer cohorts. Finally, functional enrichment analyses were provided, and a deep learning model studying the pathological images was constructed to identify the immune subtypes. Results: We identified and validated three reproducible immune subtypes presented with diverse components of tumor-infiltrating immune cells, molecular features, and clinical characteristics. An immune-inflamed subtype 3, with better prognosis and the highest immune score, had the highest abundance of CD8+ T cells, CD4+ T-activated cells, follicular helper T cells, M1 macrophages, and NK cells among three subtypes. By contrast, an immune-excluded subtype 1, with the worst prognosis and the highest stromal score, demonstrated the highest infiltration of CD4+ T resting cells, regulatory T cells, B cells, and dendritic cells, while an immune-desert subtype 2, with an intermediate prognosis and the lowest immune score, demonstrated the highest infiltration of M2 macrophages and mast cells, and the lowest infiltration of M1 macrophages. Besides, higher proportion of EVB and MSI of TCGA molecular subtyping, over expression of CTLA4, PD1, PDL1, and TP53, and low expression of JAK1 were observed in immune subtype 3, which consisted with the results from Gene Set Enrichment Analysis. These subtypes may suggest different immunotherapy strategies. Finally, deep learning can predict the immune subtypes well. Conclusion: This study offers a conceptual frame to better understand the tumor immune microenvironment of GC. Future work is required to estimate its reference value for the design of immune-related studies and immunotherapy selection.

Indexed as

Deep LearningAgedBiomarkers, TumorFemaleHumansImmunotherapyMacrophagesMaleMiddle AgedPrognosisReproducibility of ResultsStomach NeoplasmsT-LymphocytesTranscriptomeTumor MicroenvironmentBiomarkers, Tumordeep learninggastric cancerimmune subtypesimmunotherapytumor-infiltrating immune cells

Identifiers

PMID34262565
PMCPMC8273735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.